Raymond Osarogiagbon, MD, highlights the potential benefits of increasing screening rates for patients diagnosed with lung cancer and the broader US health care system.

In solid tumors, such as skin, lung, or bone and soft tissue cancer ... New Immune Boost Could Expand Access to Cancer Immunotherapy Apr. 11, 2025 — Researchers have found that tapping into the ...

The American Lung Association is turning Connecticut turquoise this May 5-11, 2025, to raise awareness about lung cancer, honor those impacted and encourage residents to take action to help end the ...

Discrepancies between patients' experiences and friends' lives can strain relationships, highlighting the need for ...

CHICAGO, Ill. (WIFR) - The annual Lung Cancer Action Week and Turquoise Takeover celebration takes place May 5-11. Buildings ...

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer.

But the presence of CHIP and TI-CH varied between cancer types. Researchers found these mutations were more common in cancers ...

Researchers from Guilin Medical University and collaborators investigated the potential role of ubiquitin-specific protease 4 (USP4) in the occurrence and development of lung adenocarcinoma.

Many Americans were forced to postpone cancer screenings — colonoscopies, mammograms and lung scans — for several months in 2020 as COVID-19 overwhelmed doctors and hospitals. But that delay in ...